<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01645358</url>
  </required_header>
  <id_info>
    <org_study_id>1222</org_study_id>
    <nct_id>NCT01645358</nct_id>
  </id_info>
  <brief_title>Helmet Ventilation in Acute Hypercapnic Respiratory Failure</brief_title>
  <official_title>Hypercapnic Acute Respiratory Failure: Is the Helmet an Effective Interface?&quot;</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Lack of tolerance to the treatment, makes the interface choice for non-invasive ventilation
      (NIV) one of the key factor. To date the helmet is rarely used in Acute Hypercapnic
      Respiratory Failure (AHRF), because of its large dead space, despite in hypoxic respiratory
      failure, it is largely employed as a &quot;rotating&quot; strategy when the facial mask is poorly
      tolerated.

      In a multicenter randomized controlled trial, the investigators will compare the clinical
      efficacy of a new helmet designed to specifically improve the performance in chronic
      obstructive pulmonary disease (COPD) versus a full face mask during an episode of AHRF.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2012</start_date>
  <completion_date type="Actual">September 2014</completion_date>
  <primary_completion_date type="Actual">September 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Arterial Blood gases</measure>
    <time_frame>at 1 hour after the start of NIV</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Arterial Blood Gases</measure>
    <time_frame>Once a day at 8 am until discharge</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Hypercapnic Respiratory Failure</condition>
  <condition>Chronic Obstructive Pulmonary Disease</condition>
  <arm_group>
    <arm_group_label>Helmet to deliver NIV</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Total Face to deliver NIV</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Helmet (Starmed)</intervention_name>
    <description>The helmet is a kind of interface similar to a hood to deliver NIV</description>
    <arm_group_label>Helmet to deliver NIV</arm_group_label>
    <other_name>Starmed Helmet</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Total Face mask (Respironics)</intervention_name>
    <description>The total face mask is the &quot;classical&quot; interface for NIV delivery</description>
    <arm_group_label>Total Face to deliver NIV</arm_group_label>
    <other_name>Respironics Performax or similar</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  pH &lt; 7,35 and PaCO2 &gt; 45 mmHg

          -  respiratory rate &gt; 20 b/min

        Exclusion Criteria:

          -  hypoxic respiratory failure

          -  coma

          -  inability to stand NIV

          -  lack of informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Sant'Orsola malpighi Hospital</name>
      <address>
        <city>Bologna</city>
        <zip>40185</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sant'Orsola Malpighi</name>
      <address>
        <city>Bologna</city>
        <zip>40185</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>October 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 22, 2012</study_first_submitted>
  <study_first_submitted_qc>July 18, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 20, 2012</study_first_posted>
  <last_update_submitted>October 5, 2014</last_update_submitted>
  <last_update_submitted_qc>October 5, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 7, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi</investigator_affiliation>
    <investigator_full_name>dr. Stefano Nava</investigator_full_name>
    <investigator_title>Chief Respiratory and Critical care</investigator_title>
  </responsible_party>
  <keyword>COPD</keyword>
  <keyword>NIV</keyword>
  <keyword>Acute Hypercapnic Respiratory Failure</keyword>
  <keyword>COPD patients with hypercapnic respiratory failure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
    <mesh_term>Respiratory Insufficiency</mesh_term>
    <mesh_term>Hypercapnia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

